Post-operative Nausea And Vomiting Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET INTRODUCTION
Postoperative nausea and vomiting (PONV) is complex and most commonly seen problem after a patient is recovering from anesthesia. In some cases, it resolves without sequelae, and in some cases, it may require unexpected hospital admission and delayed recovery room discharge. The worse PONV may further lead to increased intracranial pressure, wound dehiscence, aspiration, esophageal rupture, dehydration, and pneumothorax.
MARKET DYNAMICS
The post-operative nausea and vomiting market growth is estimated to grow due to the increasing surgeries for chronic diseases, infection and health conditions, growing adoption generic medicines to treat nausea and vomiting, and rising sales of OTC products. The growing awareness about the non-pharmaceutical treatment is likely to create vital growth opportunities for the market.
MARKET SCOPE
The "Post-operative Nausea and Vomiting Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of post-operative nausea and vomiting market with detailed market segmentation by treatment type, and distribution channel. The post-operative nausea and vomiting market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in post-operative nausea and vomiting market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The post-operative nausea and vomiting market is segmented on the basis of treatment type, and distribution channel. Based on treatment type, the market is classified as post-operative nausea and vomiting, and non-pharmacological treatment. And on the basis of distribution channel, the market is segmented as hospital and retails pharmacies, online distribution, hyper and super markets.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the post-operative nausea and vomiting market based on various segments. It also provides market size and forecast estimates from year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America (SCAM). The post-operative nausea and vomiting market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting post-operative nausea and vomiting market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the post-operative nausea and vomiting market in these regions.
By Treatment Type
By Distribution Channel
MARKET PLAYERS
The report covers key developments in the post-operative nausea and vomiting market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from post-operative nausea and vomiting market are anticipated to have lucrative growth opportunities in the future with the rising demand for post-operative nausea and vomiting market in the global market. Below mentioned is the list of few companies engaged in the post-operative nausea and vomiting market.
The report also includes the profiles of key players in post-operative nausea and vomiting market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Postoperative nausea and vomiting (PONV) is complex and most commonly seen problem after a patient is recovering from anesthesia. In some cases, it resolves without sequelae, and in some cases, it may require unexpected hospital admission and delayed recovery room discharge. The worse PONV may further lead to increased intracranial pressure, wound dehiscence, aspiration, esophageal rupture, dehydration, and pneumothorax.
MARKET DYNAMICS
The post-operative nausea and vomiting market growth is estimated to grow due to the increasing surgeries for chronic diseases, infection and health conditions, growing adoption generic medicines to treat nausea and vomiting, and rising sales of OTC products. The growing awareness about the non-pharmaceutical treatment is likely to create vital growth opportunities for the market.
MARKET SCOPE
The "Post-operative Nausea and Vomiting Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of post-operative nausea and vomiting market with detailed market segmentation by treatment type, and distribution channel. The post-operative nausea and vomiting market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in post-operative nausea and vomiting market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The post-operative nausea and vomiting market is segmented on the basis of treatment type, and distribution channel. Based on treatment type, the market is classified as post-operative nausea and vomiting, and non-pharmacological treatment. And on the basis of distribution channel, the market is segmented as hospital and retails pharmacies, online distribution, hyper and super markets.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the post-operative nausea and vomiting market based on various segments. It also provides market size and forecast estimates from year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America (SCAM). The post-operative nausea and vomiting market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting post-operative nausea and vomiting market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the post-operative nausea and vomiting market in these regions.
Post-operative Nausea And Vomiting Market Report Analysis
Post-operative Nausea And Vomiting Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Novartis AG
- GlaxoSmithKline plc
- Merck and Co., Inc
- Pfizer, Inc.
- Bayer AG
- AstraZeneca
- AbbVie
- Sanofi
- Boehringer Ingelheim Pharmaceuticals, Inc.
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Treatment Type
- Post-operative Nausea and Vomiting
- Non-pharmacological Treatment
By Distribution Channel
- Hospital and Retails Pharmacies
- Online Distribution
- Hyper and Super Markets
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The report covers key developments in the post-operative nausea and vomiting market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from post-operative nausea and vomiting market are anticipated to have lucrative growth opportunities in the future with the rising demand for post-operative nausea and vomiting market in the global market. Below mentioned is the list of few companies engaged in the post-operative nausea and vomiting market.
The report also includes the profiles of key players in post-operative nausea and vomiting market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Novartis AG
- GlaxoSmithKline plc
- Merck and Co., Inc
- Pfizer, Inc.
- Bayer AG
- AstraZeneca
- AbbVie
- Sanofi
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Teva Pharmaceutical Industries Ltd
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Post-operative Nausea And Vomiting Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Treatment Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Novartis AG
2. GlaxoSmithKline plc
3. Merck and Co., Inc
4. Pfizer, Inc.
5. Bayer AG
6. AstraZeneca
7. AbbVie
8. Sanofi
9. Boehringer Ingelheim Pharmaceuticals, Inc.
10. Teva Pharmaceutical Industries Ltd
11. Amneal Pharmaceuticals LLC
12. Apotex Corp.
13. Mylan Pharmaceuticals Inc.
14. ANI Pharmaceuticals, Inc.
15. NorthStar Rx LLC
1. Novartis AG
2. GlaxoSmithKline plc
3. Merck and Co., Inc
4. Pfizer, Inc.
5. Bayer AG
6. AstraZeneca
7. AbbVie
8. Sanofi
9. Boehringer Ingelheim Pharmaceuticals, Inc.
10. Teva Pharmaceutical Industries Ltd
11. Amneal Pharmaceuticals LLC
12. Apotex Corp.
13. Mylan Pharmaceuticals Inc.
14. ANI Pharmaceuticals, Inc.
15. NorthStar Rx LLC
Get Free Sample For